-
Professor Wei Qiang: Advancing Innovation Across the Entire Continuum of Uro-Oncology Care and Making Robots Trusted Surgical Partners | 2025 Pujiang Uro-Oncology Academic Conference
The 2025 Pujiang Uro-Oncology Academic Conference was successfully held in Shanghai on August 22–23, 2025. Centered on the theme “Precision Breakthroughs · Integrated Innovation · Optimized Continuum of Care,” the conference brought together numerous domestic and international experts to explore innovation in uro-oncology diagnosis and treatment, multidisciplinary collaboration (MDT), and translational research. Oncology Frontier –…
-
Any level of alcohol can be harmful for MASLD patients
A recent study by Prof. Wai-Kay Seto (The University of Hong Kong) and Prof. Jie Li (Drum Tower Hospital, Nanjing University Medical School), published in Alimentary Pharmacology & Therapeutics, systematically reviewed the epidemiology, pathogenic mechanisms, and prognostic impact of alcohol use in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), showing that alcohol consumption significantly…
-
Professor Guowen Lin & Professor Junlong Wu: Breaking Barriers in mCRPC Treatment — A New Era of Precision Targeting
2025 Pujiang Uro-Oncology Academic Conference 01. The Grim Reality of mCRPC Treatment Professor Junlong Wu noted that once prostate cancer progresses to the mCRPC stage, it is like entering the…
-
From Global Follower to International Mentor Award: Professor Guohua Zeng Receives One of the Highest Honors in Urology
01. A Historic Breakthrough for Chinese Urology The Ralph Clayman Mentor Award is one of the top honors in the field of urology, recognizing individuals who have made lasting and…
-
Professor Aili Zhang Interprets Immunotherapy and Targeted–Immunotherapy Combination Strategies for Renal Cell Carcinoma
2025 Pujiang Uro-Oncology Academic Conference 01. Postoperative Adjuvant Therapy: Pembrolizumab Establishes a New Milestone in Overall Survival Benefit For a long time, postoperative adjuvant therapy for high‑risk renal cell carcinoma…
-
ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held from September 24–27 in Kumamoto, Japan. This prestigious event brought together leading experts from around the world to discuss cutting-edge developments in basic hematology, immunology, stem cell research, and cell and gene therapy. One of the highlights of this…
-
CSCO 2025 │ Professor Lili Mao: Updates to Perioperative Therapy in the 2025 CSCO Melanoma Guidelines
Q1. Key Conceptual Shifts in Perioperative Therapy Prof. Lili Mao: This year’s CSCO Melanoma Guidelines introduce several important updates regarding perioperative treatment. For cutaneous melanoma, we have added recommendations for…
-
Professor Haibo Wang: Advancing Comprehensive Breast Cancer Care through Innovation and Multidisciplinary Collaboration
Key Highlights of the 2025 Conference Prof. Haibo Wang: This year’s conference retained its hallmark sessions, such as expert debates and the signature “Langya Forum,” while introducing several new and…
Connecting Medical Expertise through Media